Free Trial

COVID, COVID & More COVID

AUSSIE BONDS

A narrow overnight session saw YM close -1.0, with XM unchanged vs. settlement amid a lack of broader tier 1 headline catalysts and limited activity in the U.S. Tsy space.

  • Local COVID matters will continue to dominate, with suggestions in the press that NSW is conducting financial modelling for a lockdown in the Greater Sydney area through at least mid-September. There are also some suggestions that the NSW Treasurer will again request a restart of the JobKeeper scheme. The weekend also saw thousands protest the lockdowns across some of the country's major cities. Finally, Australia has signed an agreement for the purchase of 60mn additional Pfizer-BioNTech COVID vaccination doses, to be delivered in '22, and a further 25mn doses in '23, which would allow the country to conduct a vaccination "booster" scheme if needed.
  • A$800mn of ACGB 1.00% 21 November 2031 supply headlines the local docket on Monday.
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.